These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7646481)
1. Steps towards a mouse model of Alzheimer's disease. Crowther RA Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481 [TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse models of Alzheimer's disease: phenotype and application. Higgins GA; Jacobsen H Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255 [TBL] [Abstract][Full Text] [Related]
4. The bad seed in Alzheimer's disease. Fryer JD; Holtzman DM Neuron; 2005 Jul; 47(2):167-8. PubMed ID: 16039556 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes. MacDonald AB Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667 [TBL] [Abstract][Full Text] [Related]
6. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
8. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy. Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006 [TBL] [Abstract][Full Text] [Related]
9. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Eriksen JL; Janus CG Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762 [TBL] [Abstract][Full Text] [Related]
10. Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse. Gordon MN; Holcomb LA; Jantzen PT; DiCarlo G; Wilcock D; Boyett KW; Connor K; Melachrino J; O'Callaghan JP; Morgan D Exp Neurol; 2002 Feb; 173(2):183-95. PubMed ID: 11822882 [TBL] [Abstract][Full Text] [Related]
11. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Zhang Q; Zhang X; Sun A Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923 [TBL] [Abstract][Full Text] [Related]
12. Modeling Alzheimer's disease in transgenic mice. Duff K J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589 [TBL] [Abstract][Full Text] [Related]
13. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
14. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202 [TBL] [Abstract][Full Text] [Related]
15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
16. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686 [TBL] [Abstract][Full Text] [Related]
17. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease. Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280 [TBL] [Abstract][Full Text] [Related]
18. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
19. Cholinergic neuropathology in a mouse model of Alzheimer's disease. German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807 [TBL] [Abstract][Full Text] [Related]
20. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]